2025.05.03 (토)

  • 맑음동두천 26.0℃
  • 구름많음강릉 28.0℃
  • 구름많음서울 24.5℃
  • 맑음대전 25.8℃
  • 맑음대구 26.1℃
  • 맑음울산 22.5℃
  • 맑음광주 25.0℃
  • 구름조금부산 21.0℃
  • 맑음고창 25.3℃
  • 구름조금제주 18.9℃
  • 구름조금강화 22.5℃
  • 맑음보은 25.4℃
  • 맑음금산 26.8℃
  • 맑음강진군 22.8℃
  • 맑음경주시 28.3℃
  • 맑음거제 21.0℃
기상청 제공

'센돔' 등 타다라필제제 인기몰이..싸움은 이제 시작

심평원으로부터 2015년 하반기 신규부여 ATC코드 받은 '시알리스' 제네릭 가장 많은 건수 기록

올해 하반기 국내 제약업계에서 가장 인기를 끈 의약품은 종근당의 '센돔' 등 발기부전치료제인 '시알리스'(성분명 타다라필)의 제네릭인 것으로 나타났다.



 
팜스코어가 건강보험심사평가원의 2015년 하반기 의약품 ATC코드 목록(신규/변경)을 분석한 결과다. ATC(Anatomical Therapeutic Chemical)코드는 세계보건기구(WHO)에서 개발한 치료제군별 국제적인 의약품 분류 코드로 총 5단계로 구성되어 있으며 많은 나라에서 공통적으로 사용된다.


분석결과, 올해 하반기 신규부여 ATC코드는 총 1664건으로, 성분 별로(ATC코드 5단계)는 올해 특허가 풀린 타다라필이 가장 많은 건수를 기록했다. 전체의 6.7%인 111건이 타다라필 성분의 코드였다. 

 

이어 ▲과민성방광치료제 '솔리페나신'(베시케어) 59건(3.5%), ▲고혈압치료제 '로살탄+암로디핀'(아모잘탄/코자엑스큐) 46건(2.8%), ▲만성B형간염치료제 '엔테카비르'(바라크루드) 46건(2.8%), ▲관절염치료제 '세레콕시브'(쎄레브렉스) 43건(2.6%) 순이었다.


-2015년 하반기 신규부여 ATC코드 분석    
    
                                                                                                                (단위 : 건수, %) 

연번

ATC코드

ATC코드 명칭

신규부여

구성비

1

G04BE08

tadalafil

111

6.7

2

G04BD08

solifenacin

59

3.5

3

C09DB06

losartan and amlodipine

46

2.8

4

J05AF10

entecavir

46

2.8

5

M01AH01

celecoxib

43

2.6

6

R05X

OTHER COLD PREPARATIONS

40

2.4

7

A02X

OTHER DRUGS FOR ACID RELATED DISORDERS

30

1.8

8

D05AX52

calcipotriol, combinations

27

1.6

9

A02BC05

esomeprazole

23

1.4

10

G04CA04

silodosin

23

1.4

11

A10BH01

sitagliptin

22

1.3

12

L01BA04

pemetrexed

21

1.3

13

C10AA07

rosuvastatin

19

1.1

14

J01CR02

amoxicillin and enzyme inhibitor

19

1.1

15

A02BA

H2-receptor antagonists

17

1.0

16

A05BA

Liver therapy

17

1.0

17

R03DC03

montelukast

17

1.0

18

A11JC

Vitamins, other combinations

16

1.0

19

C10AA05

atorvastatin

16

1.0

20

N06DA02

donepezil

14

0.8

21

R07AX

Other respiratory system products

14

0.8

22

B05BA10

combinations

13

0.8

23

S01XA

Other ophthalmologicals

13

0.8

24

C10BX

HMG CoA reductase inhibitors, other combinations

12

0.7

25

J01FA09

clarithromycin

12

0.7

26

N02AX52

tramadol, combinations

12

0.7

27

N07AX02

choline alfoscerate

12

0.7

28

J06BA02

immunoglobulins, normal human, for intravascular adm.

11

0.7

29

C09CA08

olmesartan medoxomil

10

0.6

30

J02AC01

fluconazole

10

0.6

31

N02AB03

fentanyl

10

0.6

32

A02BX

Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

9

0.5

33

A10BD07

metformin and sitagliptin

9

0.5

34

A11CC05

colecalciferol

9

0.5

35

B01AX

Other antithrombotic agents

9

0.5

36

C09DB01

valsartan and amlodipine

9

0.5

37

D01AE14

ciclopirox

9

0.5

38

L01AX03

temozolomide

9

0.5

39

N01BB02

lidocaine

9

0.5

40

N06AX21

duloxetine

9

0.5

41

A02BA02

ranitidine

8

0.5

42

C09DB02

olmesartan medoxomil and amlodipine

8

0.5

43

G04CB02

dutasteride

8

0.5

44

J02AC02

itraconazole

8

0.5

45

J05AB09

famciclovir

8

0.5

46

M01AE

Propionic acid derivatives

8

0.5

47

M09AB

Enzymes

8

0.5

48

N07XX

Other nervous system drugs

8

0.5

49

S01AE05

levofloxacin

8

0.5

50

S01GA52

tetryzoline, combinations

8

0.5

51

S01GX09

olopatadine

8

0.5

52

A02BC04

rabeprazole

7

0.4

53

A06AC08

polycarbophil calcium

7

0.4

54

A10BA02

metformin

7

0.4

55

B05AA01

albumin

7

0.4

56

C08CA01

amlodipine

7

0.4

57

J06BB04

hepatitis B immunoglobulin

7

0.4

58

M01AX22

morniflumate

7

0.4

59

M03BX09

eperisone

7

0.4

60

R06AE09

levocetirizine

7

0.4

61

S01AE01

ofloxacin

7

0.4

62

S01XA20

artificial tears and other indifferent preparations

7

0.4

63

A03FA

Propulsives

6

0.4

64

A08AX

Other antiobesity drugs

6

0.4

65

A11DA01

thiamine (vit B1)

6

0.4

66

A16AX01

thioctic acid

6

0.4

67

D01AE

Other antifungals for topical use

6

0.4

68

G04CA02

tamsulosin

6

0.4

69

M05BA06

ibandronic acid

6

0.4

70

N03AX16

pregabalin

6

0.4

71

S01AA12

tobramycin

6

0.4

72

A11AA03

multivitamins and other minerals, incl. combinations

5

0.3

73

A12AX

Calcium, combinations with vitamin D and/or other drugs

5

0.3

74

C09CA01

losartan

5

0.3

75

D07AC13

mometasone

5

0.3

76

M01AB16

aceclofenac

5

0.3

77

M01AC06

meloxicam

5

0.3

78

M09AX01

hyaluronic acid

5

0.3

79

N04BC05

pramipexole

5

0.3

80

N06BA04

methylphenidate

5

0.3

81

R05CB01

acetylcysteine

5

0.3

82

R05DB27

levodropropizine

5

0.3

83

R06AX13

loratadine

5

0.3

84

S01GX08

ketotifen

5

0.3

85

V03AB32

glutathione

5

0.3

86

A03AC05

tiropramide

4

0.2

87

A07AX

Other intestinal antiinfectives

4

0.2

88

A10BX14

dulaglutide

4

0.2

89

A11EX

Vitamin B-complex, other combinations

4

0.2

90

A11JB

Vitamins with minerals

4

0.2

91

B01AC

Platelet aggregation inhibitors excl. heparin

4

0.2

92

C01EX

Other cardiac combination products

4

0.2

93

C09DA07

telmisartan and diuretics

4

0.2

94

G04CB01

finasteride

4

0.2

95

J01DC04

cefaclor

4

0.2

96

J01DD13

cefpodoxime

4

0.2

97

J01XX

Other antibacterials

4

0.2

98

L01XE02

gefitinib

4

0.2

99

M01AE01

ibuprofen

4

0.2

100

M01AE51

ibuprofen, combinations

4

0.2

101

M02AC

Preparations with salicylic acid derivatives

4

0.2

102

N02BG06

nefopam

4

0.2

103

N03AX11

topiramate

4

0.2

104

N03AX12

gabapentin

4

0.2

105

N06DX02

Ginkgo folium

4

0.2

106

R06AX24

epinastine

4

0.2

107

S01BA07

fluorometholone

4

0.2

108

V07AT

Cosmetics

4

0.2

109

A01AD

Other agents for local oral treatment

3

0.2

110

A02BA04

nizatidine

3

0.2

111

A02BX13

alginic acid

3

0.2

112

A03AA05

trimebutine

3

0.2

113

A03BB05

cimetropium bromide

3

0.2

114

A05BA03

silymarin

3

0.2

115

A06AB52

bisacodyl, combinations

3

0.2

116

A07FA01

lactic acid producing organisms

3

0.2

117

A07FA51

lactic acid producing organisms, combinations

3

0.2

118

A09A

DIGESTIVES, INCL. ENZYMES

3

0.2

119

A10BD10

metformin and saxagliptin

3

0.2

120

A12CB01

zinc sulfate

3

0.2

121

B01AC04

clopidogrel

3

0.2

122

C09CA07

telmisartan

3

0.2

123

C09DA01

losartan and diuretics

3

0.2

124

C10AA01

simvastatin

3

0.2

125

C10AX06

omega-3-triglycerides incl. other esters and acids

3

0.2

126

C10BA06

rosuvastatin and ezetimibe

3

0.2

127

D01AE15

terbinafine

3

0.2

128

D04A

ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.

3

0.2

129

D09AA

Medicated dressings with antiinfectives

3

0.2

130

D11AX

Other dermatologicals

3

0.2

131

D11AX10

finasteride

3

0.2

132

G04BE03

sildenafil

3

0.2

133

J01FA06

roxithromycin

3

0.2

134

L01XE03

erlotinib

3

0.2

135

M01AE02

naproxen

3

0.2

136

M01AE14

dexibuprofen

3

0.2

137

M02AA15

diclofenac

3

0.2

138

N02BE01

paracetamol

3

0.2

139

N02BE51

paracetamol, combinations excl. psycholeptics

3

0.2

140

N04BA03

levodopa, decarboxylase inhibitor and COMT inhibitor

3

0.2

141

N05AX08

risperidone

3

0.2

142

N05AX12

aripiprazole

3

0.2

143

N06AB10

escitalopram

3

0.2

144

N06DA03

rivastigmine

3

0.2

145

N06DX01

memantine

3

0.2

146

N07BA01

nicotine

3

0.2

147

R03CC11

tulobuterol

3

0.2

148

R05F

COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS

3

0.2

149

R05FA02

opium derivatives and expectorants

3

0.2

150

S01BC05

ketorolac

3

0.2

151

V09IX06

sodium fluoride (18F)

3

0.2

152

A02AX

Antacids, other combinations

2

0.1

153

A02BA01

cimetidine

2

0.1

154

A02BA03

famotidine

2

0.1

155

A02BC02

pantoprazole

2

0.1

156

A03AX13

silicones

2

0.1

157

A03AX58

alverine, combinations

2

0.1

158

A03FA07

itopride

2

0.1

159

A05BA06

ornithine oxoglurate

2

0.1

160

A07AX03

nifuroxazide

2

0.1

161

A10BB12

glimepiride

2

0.1

162

A10BD02

metformin and sulfonamides

2

0.1

163

A10BD13

metformin and alogliptin

2

0.1

164

A10BD15

metformin and dapagliflozin

2

0.1

165

A10BH03

saxagliptin

2

0.1

166

A13A

TONICS

2

0.1

167

A16AX

Various alimentary tract and metabolism products

2

0.1

168

B06AA03

hyaluronidase

2

0.1

169

C04AF01

kallidinogenase

2

0.1

170

C04AX

Other peripheral vasodilators

2

0.1

171

C04AX21

naftidrofuryl

2

0.1

172

C05AX03

other preparations, combinations

2

0.1

173

C09CA03

valsartan

2

0.1

174

C09CA04

irbesartan

2

0.1

175

C09DA04

irbesartan and diuretics

2

0.1

176

C09DA06

candesartan and diuretics

2

0.1

177

C09DA08

olmesartan medoxomil and diuretics

2

0.1

178

C10AB05

fenofibrate

2

0.1

179

C10BX03

atorvastatin and amlodipine

2

0.1

180

D01AC

Imidazole and triazole derivatives

2

0.1

181

D01BA02

terbinafine

2

0.1

182

D07AC18

prednicarbate

2

0.1

183

D07CC01

betamethasone and antibiotics

2

0.1

184

D08AC52

chlorhexidine, combinations

2

0.1

185

G02CB03

cabergoline

2

0.1

186

G03AA10

gestodene and ethinylestradiol

2

0.1

187

G04BD07

tolterodine

2

0.1

188

G04CA03

terazosin

2

0.1

189

J01DD01

cefotaxime

2

0.1

190

J01DE01

cefepime

2

0.1

191

J01DH02

meropenem

2

0.1

192

J01MA02

ciprofloxacin

2

0.1

193

J01MA12

levofloxacin

2

0.1

194

J01XX11

tedizolid

2

0.1

195

J06BB03

varicella/zoster immunoglobulin

2

0.1

196

J07BB02

influenza, inactivated, split virus or surface antigen

2

0.1

197

L01BC05

gemcitabine

2

0.1

198

L01CD02

docetaxel

2

0.1

199

L01DB08

pirarubicin

2

0.1

200

L01XA01

cisplatin

2

0.1

201

L01XC17

nivolumab

2

0.1

202

L01XC21

ramucirumab

2

0.1

203

L01XX19

irinotecan

2

0.1

204

L04AD02

tacrolimus

2

0.1

205

M01AC01

piroxicam

2

0.1

206

M02AA10

ketoprofen

2

0.1

207

M02AA19

flurbiprofen

2

0.1

208

M03AX01

botulinum toxin

2

0.1

209

M03BB03

chlorzoxazone

2

0.1

210

M05BA07

risedronic acid

2

0.1

211

N05AH03

olanzapine

2

0.1

212

N05AL05

amisulpride

2

0.1

213

N06AA12

doxepin

2

0.1

214

N06AB03

fluoxetine

2

0.1

215

R01AA07

xylometazoline

2

0.1

216

R03AK07

formoterol and budesonide

2

0.1

217

R03BB04

tiotropium bromide

2

0.1

218

R06AX19

azelastine

2

0.1

219

S01ED51

timolol, combinations

2

0.1

220

S01EE03

bimatoprost

2

0.1

221

S01XA18

ciclosporin

2

0.1

222

V01AA03

house dust mites

2

0.1

223

V03AF03

calcium folinate

2

0.1

224

V09IX04

fludeoxyglucose (18F)

2

0.1

225

A01AB23

minocycline

1

0.1

226

A02BC

Proton pump inhibitors

1

0.1

227

A02BC01

omeprazole

1

0.1

228

A02BC03

lansoprazole

1

0.1

229

A03

DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS

1

0.1

230

A03A

DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS

1

0.1

231

A04AA

Serotonin (5HT3) antagonists

1

0.1

232

A05AA02

ursodeoxycholic acid

1

0.1

233

A05BA01

arginine glutamate

1

0.1

234

A05BA07

tidiacic arginine

1

0.1

235

A06AB58

sodium picosulfate, combinations

1

0.1

236

A06AC01

ispaghula (psylla seeds)

1

0.1

237

A06AD10

 

mineral salts in combination

1

0.1

238

A06AD11

lactulose

1

0.1

239

A06AD65

macrogol, combinations

1

0.1

240

A06AX

Other drugs for constipation

1

0.1

241

A07XA

Other antidiarrheals

1

0.1

242

A08AA03

amfepramone

1

0.1

243

A08AA11

lorcaserin

1

0.1

244

A10BD14

metformin and repaglinide

1

0.1

245

A10BG03

pioglitazone

1

0.1

246

A10BH

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1

0.1

247

A11AB

Multivitamins, other combinations

1

0.1

248

A11CC

Vitamin D and analogues

1

0.1

249

A12CC

Magnesium

1

0.1

250

A12CE02

sodium selenite

1

0.1

251

A12CX

Other mineral products

1

0.1

252

A15

APPETITE STIMULANTS

1

0.1

253

A16AA01

levocarnitine

1

0.1

254

A16AB02

imiglucerase

1

0.1

255

A16AB12

elosulfase alfa

1

0.1

256

B01AB02

antithrombin III

1

0.1

257

B01AC19

beraprost

1

0.1

258

B01AC30

combinations

1

0.1

259

B02BD02

coagulation factor VIII

1

0.1

260

B02BD04

coagulation factor IX

1

0.1

261

B03AE01

iron, vitamin B12 and folic acid

1

0.1

262

B03AE10

various combinations

1

0.1

263

B03XA01

erythropoietin

1

0.1

264

B05BA01

amino acids

1

0.1

265

B05BA03

carbohydrates

1

0.1

266

B05XA30

combinations of electrolytes

1

0.1

267

C05AA

Corticosteroids

1

0.1

268

C05AD07

pramocaine

1

0.1

269

C05BX01

calcium dobesilate

1

0.1

270

C05CA03

diosmin

1

0.1

271

C05CX

Other capillary stabilizing agents

1

0.1

272

C07AB12

nebivolol

1

0.1

273

C08CA02

felodipine

1

0.1

274

C08CA09

lacidipine

1

0.1

275

C08CA13

lercanidipine

1

0.1

276

C09DA03

valsartan and diuretics

1

0.1

277

C10AA08

pitavastatin

1

0.1

278

D01AC14

sertaconazole

1

0.1

279

D02AB

Zinc products

1

0.1

280

D03AX

Other cicatrizants

1

0.1

281

D06AX

Other antibiotics for topical use

1

0.1

282

D06AX01

fusidic acid

1

0.1

283

D06AX08

tyrothricin

1

0.1

284

D06AX09

mupirocin

1

0.1

285

D06BA03

mafenide

1

0.1

286

D06BB03

aciclovir

1

0.1

287

D07AA03

prednisolone

1

0.1

288

D07AD01

clobetasol

1

0.1

289

D07CA01

hydrocortisone and antibiotics

1

0.1

290

D07XA01

hydrocortisone

1

0.1

291

D07XA02

prednisolone

1

0.1

292

D09A

MEDICATED DRESSINGS

1

0.1

293

D10A?

Corticosteroids, combinations for treatment of acne

1

0.1

294

D11AA

Antihidrotics

1

0.1

295

D11AX01

minoxidil

1

0.1

296

D11AX11

hydroquinone

1

0.1

297

G01AA51

nystatin, combinations

1

0.1

298

G02AD02

dinoprostone

1

0.1

299

G03AA07

levonorgestrel and ethinylestradiol

1

0.1

300

G03AA09

desogestrel and ethinylestradiol

1

0.1

301

G03AB03

levonorgestrel and ethinylestradiol

1

0.1

302

G03BA03

testosterone

1

0.1

303

G03X

OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM

1

0.1

304

G03XC01

raloxifene

1

0.1

305

G04BD06

propiverine

1

0.1

306

H01AC01

somatropin

1

0.1

307

H02AB04

methylprednisolone

1

0.1

308

H02AB09

hydrocortisone

1

0.1

309

H03AA02

liothyronine sodium

1

0.1

310

J01GB01

tobramycin

1

0.1

311

J01GB06

amikacin

1

0.1

312

J01MA

Fluoroquinolones

1

0.1

313

J01MA14

moxifloxacin

1

0.1

314

J02AC04

posaconazole

1

0.1

315

J05AB11

valaciclovir

1

0.1

316

J05AE15

asunaprevir

1

0.1

317

J05AF05

lamivudine

1

0.1

318

J05AH02

oseltamivir

1

0.1

319

J05AR13

lamivudine, abacavir and dolutegravir

1

0.1

320

J05AX14

daclatasvir

1

0.1

321

J06BB02

tetanus immunoglobulin

1

0.1

322

J07AE01

cholera, inactivated, whole cell

1

0.1

323

J07BA03

encephalitis, Japanese, live attenuated

1

0.1

324

L01

ANTINEOPLASTIC AGENTS

1

0.1

325

L01CB01

etoposide

1

0.1

326

L01DB02

daunorubicin

1

0.1

327

L01DB06

idarubicin

1

0.1

328

L01XC18

pembrolizumab

1

0.1

329

L01XE01

imatinib

1

0.1

330

L01XX

Other antineoplastic agents

1

0.1

331

L01XX05

hydroxycarbamide

1

0.1

332

L01XX32

bortezomib

1

0.1

333

L02BG04

letrozole

1

0.1

334

L03AB11

peginterferon alfa-2a

1

0.1

335

L03AX01

lentinan

1

0.1

336

L04AA31

teriflunomide

1

0.1

337

L04AA33

vedolizumab

1

0.1

338

L04AB06

golimumab

1

0.1

339

L04AC05

ustekinumab

1

0.1

340

L04AX02

thalidomide

1

0.1

341

M01AB15

ketorolac

1

0.1

342

M01AH

Coxibs

1

0.1

343

M01AX

Other antiinflammatory and antirheumatic agents, non-steroids

1

0.1

344

M02AA08

felbinac

1

0.1

345

M02AB

Capsaicin and similar agents

1

0.1

346

M02AX

Other topical products for joint and muscular pain

1

0.1

347

M05BB03

alendronic acid and colecalciferol

1

0.1

348

N02BG

Other analgesics and antipyretics

1

0.1

349

N04BA02

levodopa and decarboxylase inhibitor

1

0.1

350

N05BE01

buspirone

1

0.1

351

N05CF02

zolpidem

1

0.1

352

N06AX11

mirtazapine

1

0.1

353

N06AX12

bupropion

1

0.1

354

N06BX12

acetylcarnitine

1

0.1

355

N07BB04

naltrexone

1

0.1

356

P01BA02

hydroxychloroquine

1

0.1

357

P02CA03

albendazole

1

0.1

358

R01AD03

dexamethasone

1

0.1

359

R01B

NASAL DECONGESTANTS FOR SYSTEMIC USE

1

0.1

360

R01BA52

pseudoephedrine, combinations

1

0.1

361

R02A

THROAT PREPARATIONS

1

0.1

362

R02AA05

chlorhexidine

1

0.1

363

R03AL04

indacaterol and glycopyrronium bromide

1

0.1

364

R03AL05

formoterol and aclidinium bromide

1

0.1

365

R05CB06

ambroxol

1

0.1

366

R05CB10

combinations

1

0.1

367

R05CB15

erdosteine

1

0.1

368

R06A

ANTIHISTAMINES FOR SYSTEMIC USE

1

0.1

369

R06AE07

cetirizine

1

0.1

370

R06AX

Other antihistamines for systemic use

1

0.1

371

S01AE07

moxifloxacin

1

0.1

372

S01BA01

dexamethasone

1

0.1

373

S01BA04

prednisolone

1

0.1

374

S01BA05

triamcinolone

1

0.1

375

S01BC04

flurbiprofen

1

0.1

376

S01CA01

dexamethasone and antiinfectives

1

0.1

377

S01EA05

brimonidine

1

0.1

378

S01EC54

brinzolamide, combinations

1

0.1

379

S01ED03

levobunolol

1

0.1

380

S01FA56

tropicamide, combinations

1

0.1

381

S01GX01

cromoglicic acid

1

0.1

382

S01GX10

epinastine

1

0.1

383

S01GX11

alcaftadine

1

0.1

384

S01L

OCULAR VASCULAR DISORDER AGENTS

1

0.1

385

V03AB

Antidotes

1

0.1

386

V03AB03

edetates

1

0.1

387

V03AB25

flumazenil

1

0.1

388

V03AE02

sevelamer

1

0.1

389

V06B

PROTEIN SUPPLEMENTS

1

0.1

390

V07AB

Solvents and diluting agents, incl. irrigating solutions

1

0.1

391

V07AV

Technical disinfectants

1

0.1

392

V08AB02

iohexol

1

0.1

393

V09AB

Iodine (123I) compounds

1

0.1

394

V09BA03

technetium (99mTc) pyrophosphate

1

0.1

395

V09FX01

technetium (99mTc) pertechnetate

1

0.1

396

V09GX01

thallium (201Tl) chloride

1

0.1

합계

1,664

100.0

이들 성분이 전체에서 차지하는 비율은 18.3%로, 올해 하반기 제약업계가 집중적으로 출시한 의약품 시장의 동향을 보여주는 것이다. 

 

치료계열별(ATC코드 3단계)로는 기타 비뇨기과 약물이 176건으로 전체의 10.6%를 차지했다. 이어 NSAIDs(비스테로이드성 소염진통제) 및 류마티스치료제(5.2%), 위궤양 및 위-식도 역류질환치료제(4.7%), 고혈압복합제(4.6%), 항바이러스제(3.6%) 순으로 신규부여 코드 건수가 많았다.


가장 많은 건수를 기록한 기타 비뇨기과 약물 중 63.1%는 타다라필이었다. 이어 솔리페나신(33.5%), 기타(3.4%) 순으로 점유율이 높았다.


두번째로 많은 건수를 기록한 NSAIDs 및 류마티스치료제의 절반은 '세레브렉스' 제네릭 품목으로 조사됐다.


이들 품목은 각각 159개와 133개의 제네릭이 식약처의 허가를 받았으며 이 가운데 올해 하반기 심평원에서 ATC코드를 부여 받은 품목은 '시알리스' 제네릭 111개, '바라크루드' 제네릭 46개이다.

배너
배너

배너

행정

더보기

배너
배너

제약ㆍ약사

더보기

배너
배너
배너

의료·병원

더보기
소아암·희귀질환 환자,11,822명 진단, 5,512명 치료, 29,379건의 코호트 데이터 등록 “저는 곤충학자가 되는 게 꿈이에요. 어느 날 사슴벌레를 보았는데, 그때부터 곤충의 매력에 빠졌어요. 어린이날에는 동생과 함께 커다란 테라리움을 만들고 싶어요.” 11살 김현우 군(가명)은 자신의 꿈을 향해 한 걸음씩 나아가고 있다. 최근 만성골수성백혈병을 진단받고 치료제를 사용하며 외래 추적 관찰을 받고 있는 현우 군은 이건희 소아암·희귀질환 극복사업을 통해 소아 혈액암 환자들의 진단과 치료 향상을 위한 유전체 분석사업에 참여하고 있다. 이를 통해 그는 자신의 치료에만 그치지 않고, 다른 환자들에게도 도움이 될 치료 플랫폼 확장에 기여하고 있다. 현우 군은 아픔에서 멈추지 않으며 성장하고, 꿈을 향해 끊임없이 나아가고 있다. 현우 군처럼, 병마와 싸우면서도 자신만의 꿈을 키워가는 많은 어린이들이 있다. 이러한 어린이들에게 뜻깊은 어린이날을 선물하기 위해 서울대어린이병원 소아암·희귀질환지원사업단(단장 최은화)은 5월 2일, 서울대어린이병원 CJ홀에서 ‘우리들은 자란다’ 행사를 개최했다. 이번 행사는 어린이의 건강한 성장을 바랐던 고(故) 이건희 회장의 유지를 이어 받아, 소아암 및 희귀질환 환자들에게 희망을 전하기 위해 진행됐다. 사업단은 이번 행사에서 핵심